{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443218376
| IUPAC_name = 4-amino-''N''-(butylcarbamoyl)benzenesulfonamide
| image = Carbutamide.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|carbutamide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 339-43-5
| ATC_prefix = A10
| ATC_suffix = BB06
| ATC_supplemental =  
| PubChem = 9564
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = E3K8P4869P
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 448570
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 9189
|  smiles = O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = VDTNNGKXZGSZIP-UHFFFAOYSA-N

<!--Chemical data-->
| chemical_formula =  
| C=11 | H=17 | N=3 | O=3 | S=1 
| molecular_weight = 271.335 g/mol
}}

'''Carbutamide''' (brand name Glucidoral) is an anti-diabetic drug of the [[sulfonylurea]] class, developed by [[Servier]].

It is classified as first-generation.<ref name="pmid2106423">{{cite journal |vauthors=Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G |title=Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds |journal=Diabetes Res. Clin. Pract. |volume=8 |issue=2 |pages=109–14 |date=January 1990 |pmid=2106423 |doi= 10.1016/0168-8227(90)90020-T|url=}}</ref>

==References==
{{reflist}}

{{Oral hypoglycemics}}
{{Ion channel modulators}}

[[Category:Potassium channel blockers]]
[[Category:Sulfonylureas]]
[[Category:Anilines]]


{{gastrointestinal-drug-stub}}